Matinas biopharma announces chairman succession plan

Eric j. ende, md, mba appointed as chairman, effective october 1, 2022; founding chairman herbert j. conrad to remain an independent director of the company eric j. ende, md, mba appointed as chairman, effective october 1, 2022; founding chairman herbert j. conrad to remain an independent director of the company
MTNB Ratings Summary
MTNB Quant Ranking